BeStock  
Stocks › Biotechnology › JANX

Janux Therapeutics JANX

US equityMarket cap rank #3470Biotechnology
$10.08 −$0.21 (-2.04%)
Market closed · Nov 20, 8:20 pm ET · Last extended-hours $10.15 +0.69%
Open$10.11
Prev close$10.29
Day range$10.05 – $10.54
Volume1.11M
Market cap$616.73M
P/E (TTM)–
Dividend yield–

Valuation

Multiples measured against the stock's own five-year history

Price / earnings-7.2x
CheapRich

Near the top of its 5-year range · 88th percentile, 5-year average -16.9x

Price / book0.8x
CheapRich

Near the bottom of its 5-year range · 0th percentile, 5-year average 2.1x

#1026 of 5329 stocks by PB (1 = cheapest)

Price / sales29.9x
CheapRich

Near the bottom of its 5-year range · 0th percentile, 5-year average 306.4x

#4802 of 5155 stocks by PS (1 = cheapest)

P/E over five years

-66x-44x-21x1xOct '21Apr '24Nov '26

Dashed line is the 5-year average; the shaded band is one standard deviation either side.

Morningstar fair value estimate

Fair value$24.95
Price vs. fair value-59.6%Trading below the estimate
Star rating★★★★★
Economic moatNone
UncertaintyVery High
MultipleCurrentForward5y averagePercentile vs. own historyIndustry rank
PB 0.76 – 2.08 0% (cheaper than usual) #1026 of 5329 (1 = cheapest)
PE -7.15 -4.80 -16.91 88% (pricier than usual) –
PS 29.87 89.07 306.37 0% (cheaper than usual) #4802 of 5155 (1 = cheapest)

Percentile is against this stock’s own 5-year valuation range: higher means it’s trading rich relative to its own history, lower means cheap relative to its own history — it is not a comparison against other companies. Forward multiples use consensus estimates for the next twelve months; a forward multiple below the current one usually signals analysts expect earnings to grow.

Discussion

No comments yet — be the first to weigh in on JANX.

Sign in to join the discussion.

Scroll to Top